Newamsterdam Pharma Co Nv (NAMS)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 667 |
| % of all portfolios: | 0.006% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
3 |
$184,991 |
| Sells |
5 |
$2,027,787 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 30 Sep 2024 |
AUDET JULIETTE BERANGERE |
Chief Business Officer |
26 Sep 2024 |
1,104 |
15.70 |
17,333 |
| 22 Aug 2024 |
DAVIDSON MICHAEL H. |
Chief Executive Officer |
20 Aug 2024 |
5,000 |
16.27 |
81,350 |
| 24 Jun 2024 |
DAVIDSON MICHAEL H. |
Chief Executive Officer |
20 Jun 2024 |
5,000 |
17.26 |
86,308 |
| 28 Mar 2024 |
TOPPER JAMES N |
Director |
26 Mar 2024 |
8,429 |
21.50 |
181,224 |
| 21 Feb 2024 |
LANGE LOUIS G |
Director |
13 Feb 2024 |
5,000 |
19.00 |
95,000 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock